Fudan University Shanghai Cancer Center
Xiaojian Qin, MD, PhD, Fudan University Shanghai Cancer Center.
Dr. Qin fulfilled his study plan in Fudan University Shanghai Medical College, one of China’s leading medical academies in 2001. There he started his medical journal and participated actively in regional and national-wide health services. By clinical practice and scientific exploration in the professional field, his innovative work was widely recognized.
Recognized as one of the young global cancer leaders of UICC, Dr. Qin put great effort into the foundation of Urologic Chinese Oncology Group (UCOG) , a non-profit academic community composed with a growing number up to 33 top level multi-disciplinary teams in China in the management of urologic cancers, and is titled chief secretary by the group.
Dr. Qin helped build China urologic oncology and intelligent robot joint innovation center,as the executive director. By the first time, this innovation center introduced artificial intelligence service into the management of urologic cancers in China.
Dr. Qin, as the executive director, helped China GU MDT consultation platform grow up to the most extensive and professional platform in China to overcome the uneven level in the management of GU cancers, and to enhance the accessibility of GU MDT service. The project will also make the technology and medical service transcend the boundary of administrative division and institution. The platform was awarded as “top brands of medical services” by Fudan University and local government of Shanghai, and was introduced to the 2018 annual congress of European Urology Association.
Responsibility, courage and innovation are deeply engraved in Dr. Qin’s medicine spirit. As a promising doctor and scholar, he believes in professional training and strives to become a leader in his dedicated field. With a socialistic mindset, he will make his efforts in public health and health policies to benefit people in a broader range.